Close Menu

NEW YORK (360Dx) – The strategic alliance announced earlier this month between NeoGenomics and Pharmaceutical Product Development (PPD) is expected to boost the companies' oncology companion diagnostics services by combining NeoGenomics oncology expertise with PPD's global contract research organization services, the companies said.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.